MH
Therapeutic Areas
Metaba Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Oxysterol-based Antimicrobial Program | Drug-resistant Mycobacterium tuberculosis (TB) | Preclinical |
| Oxysterol-based Antimicrobial Platform Expansion | Other drug-resistant bacterial infections | Discovery/Preclinical |